| 000 | 01644 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512202827.0 | ||
| 264 | 0 | _c19830505 | |
| 008 | 198305s 0 0 eng d | ||
| 022 | _a0002-9343 | ||
| 024 | 7 |
_a10.1016/0002-9343(83)91029-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbbruzzese, J L | |
| 245 | 0 | 0 |
_aProspective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cApr 1983 |
||
| 300 |
_a694-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCephalosporins _xtherapeutic use |
| 650 | 0 | 4 |
_aCephamycins _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFever _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMoxalactam |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aStreptococcal Infections _xcomplications |
| 650 | 0 | 4 |
_aTobramycin _xtherapeutic use |
| 650 | 0 | 4 |
_aUrinary Tract Infections _xcomplications |
| 700 | 1 | _aRocco, L E | |
| 700 | 1 | _aLaskin, O L | |
| 700 | 1 | _aSkubitz, K M | |
| 700 | 1 | _aMcGaughey, M D | |
| 700 | 1 | _aLipsky, J J | |
| 773 | 0 |
_tThe American journal of medicine _gvol. 74 _gno. 4 _gp. 694-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9343(83)91029-x _zAvailable from publisher's website |
| 999 |
_c6220601 _d6220601 |
||